Metabolomics analysis for biomarker discovery: advances and challenges

M S Monteiro1, M Carvalho, M L Bastos

  • 1REQUIMTE, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, Porto University, Portugal. mtacf10006@ff.up.pt

Summary

Metabolomics, the study of all metabolites, offers sensitive and specific biomarker discovery for diseases. Despite challenges, advances enhance its clinical health applications.